Press release
Preeclampsia Drugs Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Preeclampsia Drugs Market Size
The preeclampsia drugs market has grown rapidly in recent years. It will grow from $1.25 billion in 2024 to $1.38 billion in 2025, at a CAGR of 10.6%. The growth is due to increased awareness of maternal health, ongoing research and development, neonatal health concerns, and early detection efforts.
The preeclampsia drugs market is forecast to grow rapidly, reaching $2.12 billion by 2029, with a CAGR of 11.3%. The expansion is driven by personalized medicine, non-invasive diagnostic tools, targeted therapies, and health equity initiatives. Key trends include preventive strategies, patient-centered care, continuous monitoring, and regulatory focus.
What Key Elements Are Boosting Growth in the Preeclampsia Drugs Market?
The increasing prevalence of diabetes among pregnant women is projected to drive the growth of the preeclampsia drug market. Diabetes is a chronic metabolic condition characterized by elevated blood sugar levels, which can contribute to the development of preeclampsia, a pregnancy complication involving high blood pressure and potential organ damage. Medications such as Metformin are commonly prescribed for pregnant women at risk of preeclampsia. For instance, according to the National Library of Medicine, the total incidence of gestational diabetes mellitus (GDM) was 20,865 cases in December 2022, marking a 6.56% increase. As a result, the rising number of diabetes cases among pregnant women is fueling the growth of the preeclampsia drug market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13025&type=smp
Who Are the Major Industry Players Fueling Preeclampsia Drugs Market Expansion?
Major companies operating in the preeclampsia drugs market are AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc.
Which Key Developments Are Influencing the Preeclampsia Drugs Market?
Key players in the preeclampsia medicine market are developing innovative drug solutions to strengthen their market position. For instance, in March 2023, Comanche Biopharma Corp., a US-based biopharmaceutical company, announced FDA approval for an investigational new drug (IND) application for CBP-4888, Comanche's proprietary siRNA therapy for preeclampsia. CBP-4888 is a subcutaneously administered siRNA therapy that reduces the production of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta. Overproduction of sFLT1 in the placenta is the primary cause of preeclampsia, as it enters the mother's bloodstream. CBP-4888 helps alleviate symptoms such as high blood pressure and organ damage and may enable a safer extension of pregnancy.
How Is the Segmentation of the Preeclampsia Drugs Market Defined?
The preeclampsia drugs market covered in this report is segmented -
1) By Type: Mild Preeclampsia, Severe Preeclampsia
2) By Treatment: Medication to Lower Hypertension (B.P), Corticosteroids, Anticonvulsants Medication
3) By Route of Administration: Oral, Parenteral, Other Route of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Mild Preeclampsia: Blood Pressure Management, Proteinuria Monitoring, Lifestyle Modifications
2) By Severe Preeclampsia: Antihypertensive Medications, Magnesium Sulfate Therapy, Emergency Delivery Management
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report
What Is the Leading Region in the Preeclampsia Drugs Market?
North America was the largest region in the preeclampsia drugs market in 2024. The regions covered in preeclampsia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Preeclampsia Drugs Global Market Report?
- Market Size Analysis: Analyze the Preeclampsia Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Preeclampsia Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Preeclampsia Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Preeclampsia Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13025
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preeclampsia Drugs Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3854284 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Preeclampsia
Emerging Preeclampsia Drugs Market Trends: Leading Companies In The Preeclampsia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Preeclampsia Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs used in the treatment of preeclampsia has seen a swift escalation in the recent past. This market is projected to soar from a value of $1.25 billion in 2024 to $1.38 billion in…
Preeclampsia Diagnostics Market Current Status and Future Prospects till 2033
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 8.5% from 2026 to 2033, reaching USD 2.4 Billion by 2033.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
Q1: What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand…
Preeclampsia Drugs Market Report 2025-2034: Industry Overview, Trends, And Forec …
The Preeclampsia Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Preeclampsia Drugs Market Size and Its Estimated Growth Rate?
In recent times, there has been a swift expansion in the market size of drugs for preeclampsia. The market, which is expected…
Preeclampsia Diagnostics Market | Exploring Current Trends and Growth Status for …
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand for…
Preeclampsia Diagnostics Market Forecast Report 2032
Preeclampsia Diagnostics Market By Test Type (Blood Test, Urine Test, Others), By Product & Services (Instruments, Reagents & Consumables, Services), By End-User (Hospitals, Diagnostic Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
The preeclampsia diagnostics market [https://www.acutemarketreports.com/report/preeclampsia-diagnostics-market] is expected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2032. This growth will be driven by developments in the discovery of biomarkers, the…
Preeclampsia Market Size, Share, Trends, Report and Forecast 2024-2032
The preeclampsia market size is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, driven by advancements in early detection and monitoring along with growing hypertension prevalence across major markets.
Preeclampsia: Introduction
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, often the kidneys. It usually occurs after 20 weeks of pregnancy in women whose blood pressure had been…
